Methyl ((R)-2-((S)-2-((3-((3-((S)-1-((methoxycarbonyl)-L-valyl)pyrrolidine-2-carboxamido)phenyl)ethynyl)phenyl)carbamoyl)pyrrolidin-1-yl)-2-oxo-1-phenylethyl)carbamate

ID: ALA5189551

Chembl Id: CHEMBL5189551

PubChem CID: 168282835

Max Phase: Preclinical

Molecular Formula: C41H46N6O8

Molecular Weight: 750.85

Associated Items:

Names and Identifiers

Canonical SMILES:  COC(=O)N[C@H](C(=O)N1CCC[C@H]1C(=O)Nc1cccc(C#Cc2cccc(NC(=O)[C@@H]3CCCN3C(=O)[C@H](NC(=O)OC)c3ccccc3)c2)c1)C(C)C

Standard InChI:  InChI=1S/C41H46N6O8/c1-26(2)34(44-40(52)54-3)38(50)46-22-10-18-32(46)36(48)42-30-16-8-12-27(24-30)20-21-28-13-9-17-31(25-28)43-37(49)33-19-11-23-47(33)39(51)35(45-41(53)55-4)29-14-6-5-7-15-29/h5-9,12-17,24-26,32-35H,10-11,18-19,22-23H2,1-4H3,(H,42,48)(H,43,49)(H,44,52)(H,45,53)/t32-,33-,34-,35+/m0/s1

Standard InChI Key:  FHUDTUVXTASMDZ-AYXCPNKJSA-N

Alternative Forms

  1. Parent:

    ALA5189551

    ---

Associated Targets(Human)

Huh-5-2 (386 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

Hepatitis C virus (23859 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Topical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 750.85Molecular Weight (Monoisotopic): 750.3377AlogP: 4.42#Rotatable Bonds: 10
Polar Surface Area: 175.48Molecular Species: NEUTRALHBA: 8HBD: 4
#RO5 Violations: 1HBA (Lipinski): 14HBD (Lipinski): 4#RO5 Violations (Lipinski): 2
CX Acidic pKa: 12.50CX Basic pKa: CX LogP: 4.46CX LogD: 4.46
Aromatic Rings: 3Heavy Atoms: 55QED Weighted: 0.22Np Likeness Score: -0.75

References

1. Abdallah M, Hamed MM, Frakolaki E, Katsamakas S, Vassilaki N, Bartenschlager R, Zoidis G, Hirsch AKH, Abdel-Halim M, Abadi AH..  (2022)  Redesigning of the cap conformation and symmetry of the diphenylethyne core to yield highly potent pan-genotypic NS5A inhibitors with high potency and high resistance barrier.,  229  [PMID:34959173] [10.1016/j.ejmech.2021.114034]

Source